Severe cutaneous drug reactions in children

被引:0
|
作者
Mockenhaupt, Maja [1 ,2 ]
机构
[1] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Freiburg, Germany
[2] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Hauptstr 7, D-79104 Freiburg, Germany
关键词
Epidermal necrolysis; Drug reaction with eosinophilia and systemic symptoms; Anticonvulsants; Sulfonamides; Sulfasalazine; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; SYSTEMIC SYMPTOMS; MULTIFORME MAJUS; DRESS; EPIDEMIOLOGY; SCORTEN;
D O I
10.1007/s00112-023-01753-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as "epidermal" or "epithelial necrolysis" (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended.
引用
收藏
页码:439 / 451
页数:13
相关论文
共 50 条
  • [21] Severe cutaneous adverse drug reactions: Diagnostic approach
    Perello, M., I
    Costa, E.
    Porto, L. C. S.
    Kuschnir, F. C.
    Arraes, A. C. N.
    Conte, S.
    Castro, A.
    Dias, G. A. C.
    ALLERGY, 2019, 74 : 9 - 9
  • [22] NETosis Contributes to Severe Cutaneous Adverse Drug Reactions
    Brownell, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (04) : 992 - 992
  • [23] HLA PHENOTYPES IN SEVERE CUTANEOUS DRUG-REACTIONS
    ROUJEAU, JC
    BRACQ, C
    BAGOT, M
    BIERLING, P
    DUEDARI, N
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 432 - 432
  • [24] The evaluation of patients developed severe cutaneous drug reactions
    Guvenir, H.
    Misirlioglu, Dibek E.
    Capanoglu, M.
    Vezir, E.
    Toyran, M.
    Civelek, E.
    Buyuktiryaki, B.
    Ginis, T.
    Kocabas, C.
    ALLERGY, 2016, 71 : 264 - 264
  • [25] Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions
    Guvenir, Hakan
    Arikoglu, Tugba
    Vezir, Emine
    Misirlioglu, Emine Dibek
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (36) : 3840 - 3854
  • [26] Pharmacogenetic markers of severe cutaneous adverse drug reactions
    Borroni, R. G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2014, 149 (02): : 219 - 226
  • [27] The Value of HLA Typing in Severe Cutaneous Drug Reactions
    Khan, Sujoy
    Ghosh, Biswajit
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (02) : 162 - 163
  • [28] Cutaneous drug reactions in children: a multicentric study
    Dilek, Nursel
    Ozkol, Hatice Uce
    Akbas, Ayse
    Kilinc, Fadime
    Dilek, Aziz Ramazan
    Saral, Yunus
    Metin, Ahmet
    Calka, Omer
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2014, 31 (06): : 368 - 371
  • [29] PHARMACOGENETICS OF DRUG-INDUCED SEVERE CUTANEOUS ADVERSE DRUG REACTIONS
    Chung, Wen-Hung
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S16 - S16
  • [30] Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children
    Manuyakorn, Wiparat
    Likkasittipan, Plernpit
    Wattanapokayakit, Sukanya
    Suvichapanich, Supharat
    Inunchot, Wimala
    Wichukchinda, Nuanjun
    Khongkhatithuml, Chaiyos
    Thampratankul, Lunliya
    Kamchaisatian, Wasu
    Benjaponpitak, Suwat
    Mahasirimongkol, Surakameth
    EPILEPSY RESEARCH, 2020, 162